tirzepatide and hydroxyzine Tirzepatide Overview Tirzepatide | DirectMeds
Description
The 2023 systematic review in Clinical Gastroenterology found that gastroparesis symptoms in GLP-1 users often persisted even after dose reduction or discontinuation, suggesting potential permanent damage to gastric neuromuscular function
In: UpToDate, Basow, DS (Ed), Waltham, MA
This is the dose considered best for you to achieve long-term results with minimal side effects
Case study I am 58, obese (BMI 35), with pre-diabetes (borderline Type 2), hypothyroidism (on 50 microg thyroxine), high cholesterol, and multiple sclerosis
Most of these reactions stem from the physical trauma of injection rather than an allergic response to the medication itself
rather, it may trigger a temporary increase in shedding during the initial phases of treatment
